Literature DB >> 27338223

When is the stability of a fracture fixation limited by osteoporotic bone?

Lukas Konstantinidis1, Peter Helwig1, Anja Hirschmüller1, Elia Langenmair1, Norbert P Südkamp1, Peter Augat2.   

Abstract

This article is concerned with the search for threshold values for bone quality beyond which the risk of fixation failure increased. For trochanteric fractures we recognized a BMD lower than 250mg/cm(3) as an additional risk for cut out. For medial femoral neck fractures since joint replacement surgery is available and produces excellent functional results, we see no indication for further differentiation or analysis of bone quality in relation to fracture fixation. In the area of osteoporotic vertebral body fractures, there are many experimental studies that try to identify BMD limits of screw fixation in the cancellous bone on the basis of QCT analysis. However, these values have not yet been introduced for application in clinical practice. In case of indication for surgical fixation, we favor minimally invasive, bisegmental, fourfold dorsal instrumentation with screw-augmentation for a T-value less than -2.0 SD (DXA analysis, total hip or total lumbar spine). For proximal humerus fractures, BMD value of 95mg/cm(3) could be seen as a threshold value below which the risk of failure rises markedly. In relation to osteoporotic distal radius fractures, based on our clinical experience and scientific analyses there are virtually no restrictions as far as bone quality is concerned on the application of palmar locking implants in the surgical management of distal radius fractures. Optimization of preoperative diagnostics might help to revise the treatment algorithm to take bone density into account, thus reducing the risk of failure and, at the same time, acquiring additional data for future reference.
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Failure; Fracture fixation; Osteoporotic bone; Stability

Mesh:

Year:  2016        PMID: 27338223     DOI: 10.1016/S0020-1383(16)47005-1

Source DB:  PubMed          Journal:  Injury        ISSN: 0020-1383            Impact factor:   2.586


  6 in total

Review 1.  The "Three in One" Bone Repair Strategy for Osteoporotic Fractures.

Authors:  Xiao Chen; Yan Hu; Zhen Geng; Jiacan Su
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

2.  Immersion in Raloxifene does not significantly improve bone toughness or screw pull-out strength in multiple in vitro models.

Authors:  Michael R Eby; Danielle M Cristino; Matthew Counihan; Kendall M Masada; Jaimo Ahn; Michael W Hast
Journal:  BMC Musculoskelet Disord       Date:  2021-05-22       Impact factor: 2.362

3.  Development and first biomechanical validation of a score to predict bone implant interface stability based on clinical qCT scans.

Authors:  Dirk Wähnert; Andre Frank; Michael J Raschke; Dominic Gehweiler; Johanna Ueberberg; Lukas F Heilmann; Odile Sauzet
Journal:  Sci Rep       Date:  2021-02-08       Impact factor: 4.379

4.  Opportunistic Osteoporosis Screening Reveals Low Bone Density in Patients With Screw Loosening After Lumbar Semi-Rigid Instrumentation: A Case-Control Study.

Authors:  Maximilian T Löffler; Nico Sollmann; Egon Burian; Amirhossein Bayat; Kaywan Aftahy; Thomas Baum; Bernhard Meyer; Yu-Mi Ryang; Jan S Kirschke
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-11       Impact factor: 5.555

5.  Greater rate of cephalic screw mobilisation following proximal femoral nailing in hip fractures with a tip-apex distance (TAD) and a calcar referenced TAD greater than 25 mm.

Authors:  Rocco Aicale; Nicola Maffulli
Journal:  J Orthop Surg Res       Date:  2018-05-02       Impact factor: 2.359

6.  Bone structure determined by HR-MDCT does not correlate with micro-CT of lumbar vertebral biopsies: a prospective cross-sectional human in vivo study.

Authors:  Matthias Pumberger; Ahi Sema Issever; Torsten Diekhoff; Christin Schwemmer; Susanne Berg; Yannick Palmowski; Michael Putzier
Journal:  J Orthop Surg Res       Date:  2020-09-10       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.